November 2023 Medical Device Handbook: Breaking new ground in medtech

How Abbott designed the world’s first dual-chamber leadless pacemaker system J&J used RWE for expanded indications — and you can, too Moon Surgical thinks Maestro’s light touch can win the surgical robotics arms race Breaking new ground in medtech This year has brought a flurry of firsts from medical device manufacturers as they develop new and improved products despite continued supply chain and economic challenges. These device innovations have been in the works for years, pushed forward by teams ranging from small startups to the world’s largest medtech companies — and all with help from outsourcing partners. All of these industry players have come together once again in our latest edition of the Medical Design & Outsourcing Medical Device Handbook to offer uniquely relevant and actionable advice for device designers and engineers. This edition includes tips and advice on components, drug delivery, manufacturing, machining, molding, materials, orthopedics, product design, development, regulatory matters, reimbursement, software, and tubing. All of these articles are also available in our online Medical Device Handbook, which includes content across all of those categories from previous handbook editions. Learn from the teams behind: Abbott’s dual-chamber, leadless pacemakers; LimFlow’s breakthrough system for saving feet from amputation; Canary Medical’s smart ortho implant; iRhythm’s next-generation cardiac monitoring patch; Medtronic’s Harmony transcatheter pulmonary valve; Insulet’s Omnipod 5 automated insulin delivery system; Stryker’s cementless knee; expanded indications for J&J MedTech products using real-world evidence; and surgical robotics systems from Intuitive and Moon Surgical. You’ll find all this and more in our latest Medical Device Handbook. As always, I hope you enjoy this edition of Medical Design & Outsourcing — and thanks for reading. – Jim Hammerand, Managing Editor Medical Design & Outsourcing jhammerand@wtwhmedia.com
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.